Here, a retrospective, multicenter, collaborative study was performed to investigate the clinical characteristics, treatment strategy, and survival results of AR in metastatic NSCLC patients treated with PD1/PD-L1 inhibitor. The gene discussed is CD274; the disease is non-small cell lung carcinoma.